ERα関連トランスロケーションは,乳がんにおける腫瘍遺伝子の増幅の根底にある
Jake June-Koo Lee1,2,3, Youngsook Lucy Jung4,5, Taek-Chin Cheong6
1Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. leej39@mskcc.org.
Nature
|May 17, 2023
まとめ
乳がんにおける焦点増幅は,クロモソームの転位と断裂を含むプロセスである転位-ブリッジ増幅から生じる. エストロゲンはこれらの転位を誘発し,腫瘍遺伝子の増幅を促す可能性があります.
科学分野:
- ゲノミクス
- 癌 生物学
- 分子腫瘍学
背景:
- 焦点複製数の増幅は,がんにおける重要な腫瘍発生現象である.
- 腫瘍遺伝子の増幅の起源はほとんど不明である.
- 以前の研究では アンプリカンの構造と進化は調べましたが 始まりは調べられませんでした
研究 の 目的:
- 乳がんにおける焦点増幅の仕組みを解明する.
- 腫瘍遺伝子の増幅の開始イベントと潜在的なドライバーを特定する.
- 乳がん増殖の起源におけるエストロゲンの役割を調査する.
主な方法:
- 焦点増幅のパターンを特定するために 780 の乳がんゲノムを分析した.
- トランスロケーション・ブリッジの増幅メカニズムをモデル化する.
- エストロゲン治療とDNA破裂分析による実験的検証
- 増幅メカニズムの全がん分析
主要な成果:
- 焦点増幅はしばしば染色体間の転位によって関連付けられます.
- 二重染色体,破裂,染色体外DNA形成を含む転位ブリッジ増幅モデルが提案された.
- エストロゲン受容体結合部位は増幅境界と再配置ホットスポットと相関する.
- エストロゲン治療は転位を誘導し,増幅の開始に役割を果たすことを示唆しています.
結論:
- トランスロケーション・ブリッジ増幅は,乳がんにおける焦点腫瘍遺伝子の増幅の一般的なメカニズムである.
- エストロゲンはこれらの増幅を開始するメカニズム的な役割を果たします.
- 増幅メカニズムは組織によって変化し,DNA修復のタイミングに影響されます.
さらに関連する動画
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.3K
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
23.4K
関連する概念動画
01:33Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
02:38The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.2K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K